Improving Minority Health by Monitoring Medicaid Quality, Disparities and Value

通过监测医疗补助质量、差异和价值来改善少数群体的健康

基本信息

  • 批准号:
    10169888
  • 负责人:
  • 金额:
    $ 19.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-20 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Schizophrenia is a serious mental illness associated with a high burden of disease due to severe disability and premature mortality largely driven by co-occurring chronic medical conditions that shorten life expectancy by at least 20 years. The broad array of services needed by this population are primarily financed by Medicaid. Despite high costs, most patients do not receive recommended care, and minorities are less likely to do so than whites. These pre-existing disparities and the profound social disadvantage also experienced by this population make them particularly vulnerable to the devastation caused by the COVID-19 pandemic, which in the US has been particularly severe in the state of New York. New Yorkers with schizophrenia, and minorities in particular, are not only a high-risk group for poorer COVID-19 outcomes but they may also experience declines in their health due to disruptions in their ability to access healthcare. Although New York’s Medicaid program authorized the use of telehealth to mitigate those disruptions soon after the Governor declared a State of Emergency in early March 2020, the degree to which telehealth has been adopted by Medicaid providers serving seriously mentally ill people and whether the effects of telehealth adoption may vary by race/ethnicity are not well known. Our proposed administrative supplement application builds on our ongoing NIMHD-funded parent study (MD012428), which seeks to reduce healthcare disparities and thus improve health outcomes of racial/ethnic minority populations through measurement of quality disparities and value (or cost-effectiveness) of Medicaid-financed care delivered to adults with schizophrenia. Consistent with the NIMHD’s Notice of Special Interest calling for studies of the impact of the COVID-19 outbreak on health disparity populations, we propose to evaluate the effects of the outbreak on the racially/ethnically diverse population of Medicaid beneficiaries with schizophrenia living in New York. In Aim 1, we will assess the effect of the outbreak on racial/ethnic disparities in access, quality, and effectiveness of mental and physical healthcare delivered to our study population. In Aim 2, we will assess Medicaid providers’ responses to the outbreak and their effects on healthcare disparities in our study population. We will characterize provider response through a measure of provider readiness to adopt telehealth. Our general approach to assessing the impact of the outbreak on healthcare outcomes and the impact of provider responses on those outcomes will involve the use of post-pre outbreak differences, interrupted time series approaches, as well as approaches that utilize time-varying coefficients. In all analyses, our primary interest are parameters that describe how race/ethnicity moderates the outbreak’s effect on outcomes and the providers’ responses on outcomes. We expect that our work will provide policymakers with a better understanding of the impacts of the outbreak on vulnerable populations and enable the design of more effective policies to address this and future crises.
项目摘要 精神分裂症是一种严重的精神疾病,由于严重残疾, 过早死亡主要是由同时发生的慢性疾病造成的,这些疾病使预期寿命缩短 至少20年这一人群所需的各种服务主要由医疗补助提供资金。 尽管费用高昂,但大多数患者并没有得到推荐的护理,少数人也不太可能这样做 比白人。这些预先存在的差距和深刻的社会劣势也经历了这一点, 人口众多使他们特别容易受到COVID-19大流行造成的破坏, 美国在纽约州的情况尤为严重。患有精神分裂症的纽约人, 特别是,不仅是COVID-19结果较差的高风险群体,而且他们还可能经历 由于他们获得医疗保健的能力受到干扰,他们的健康状况下降。虽然纽约的医疗补助 在州长宣布一个州成立后不久,一项计划授权使用远程医疗来减轻这些中断 在2020年3月初,医疗补助提供者采用远程医疗的程度 为严重精神病患者提供服务,以及采用远程医疗的影响是否因种族/民族而异 并不广为人知。我们提出的行政补充申请建立在我们正在进行的NIMHD资助的 母研究(MD 012428),旨在减少医疗保健差异,从而改善 通过衡量质量差距和价值(或成本效益), 由医疗补助资助的对成年精神分裂症患者的治疗。与NIMHD的通知一致, 特别关注呼吁研究COVID-19疫情对健康差距人群的影响,我们 建议评估疫情对医疗补助计划的种族/民族多样化人群的影响 受益人患有精神分裂症住在纽约。在目标1中,我们将评估疫情对 种族/民族差异的获取,质量和精神和身体保健的有效性提供给我们 研究人群。在目标2中,我们将评估医疗补助提供者对疫情的反应及其对 我们研究人群中的医疗保健差异。我们将通过以下措施来描述供应商的响应: 提供者准备采用远程保健。我们评估疫情影响的一般方法 医疗保健结果和提供者的反应对这些结果的影响将涉及使用后前 爆发差异、中断时间序列方法以及利用时变方法的方法 系数在所有分析中,我们的主要兴趣是描述种族/民族如何调节 疫情对结果的影响以及提供者对结果的反应。我们希望我们的工作将提供 决策者更好地了解疫情对弱势群体的影响, 制定更有效的政策来应对当前和未来的危机。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Healthcare Access for a Diverse Population with Schizophrenia Following the Onset of the COVID-19 Pandemic.
  • DOI:
    10.1007/s10597-023-01105-1
  • 发表时间:
    2024-01
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Horvitz-Lennon, Marcela;Leckman-Westin, Emily;Finnerty, Molly;Jeong, Junghye;Tsuei, Jeannette;Zelevinsky, Katya;Chen, Qingxian;Normand, Sharon-Lise T.
  • 通讯作者:
    Normand, Sharon-Lise T.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marcela V Horvitz-Lennon其他文献

Marcela V Horvitz-Lennon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marcela V Horvitz-Lennon', 18)}}的其他基金

Robust Learning Approaches for Assessing Effects and Effect Heterogeneity of Real World Antipsychotic Treatment Regimes in Elderly Persons with Schizophrenia
用于评估现实世界抗精神病药物治疗方案对老年精神分裂症患者的效果和效果异质性的稳健学习方法
  • 批准号:
    10584971
  • 财政年份:
    2022
  • 资助金额:
    $ 19.72万
  • 项目类别:
Improving Minority Health by Monitoring Medicaid Quality, Disparities and Value
通过监测医疗补助质量、差异和价值来改善少数群体的健康
  • 批准号:
    9911999
  • 财政年份:
    2017
  • 资助金额:
    $ 19.72万
  • 项目类别:
Improving Value of Publicly Funded Mental Health Care
提高公共资助的精神卫生保健的价值
  • 批准号:
    9275022
  • 财政年份:
    2016
  • 资助金额:
    $ 19.72万
  • 项目类别:
Improving Value of Publicly Funded Mental Health Care
提高公共资助的精神卫生保健的价值
  • 批准号:
    9027083
  • 财政年份:
    2016
  • 资助金额:
    $ 19.72万
  • 项目类别:
An In-Depth Investigation of Racial & Ethnic Disparities in Schizophrenia Care
对种族的深入调查
  • 批准号:
    8139114
  • 财政年份:
    2010
  • 资助金额:
    $ 19.72万
  • 项目类别:
An In-Depth Investigation of Racial & Ethnic Disparities in Schizophrenia Care
对种族的深入调查
  • 批准号:
    7982863
  • 财政年份:
    2010
  • 资助金额:
    $ 19.72万
  • 项目类别:
An In-Depth Investigation of Racial & Ethnic Disparities in Schizophrenia Care
对种族的深入调查
  • 批准号:
    8301733
  • 财政年份:
    2010
  • 资助金额:
    $ 19.72万
  • 项目类别:
An In-Depth Investigation of Racial & Ethnic Disparities in Schizophrenia Care
对种族的深入调查
  • 批准号:
    8519860
  • 财政年份:
    2010
  • 资助金额:
    $ 19.72万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 19.72万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了